Future clinical and economic impact of revision total hip and knee arthroplasty.

By S. Kurtz, K. Ong, J. Schmier, F. Mowat, K. Saleh, E. Dybvik, J. Kärrholm, G. Garellick, L. Havelin, O. Furnes and 2 more. Journal of Bone and Joint Surgery. American volume, 2007

647 citations recorded by the source corpus.

Subfields: Surgery

View Paper: https://www.semanticscholar.org/paper/8b84ae1d9542c3172134877a69e28c141b4c1c5a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Surgery

1. J. Parvizi
2. S. Kurtz
3. E. Lau
4. J. Schmier
5. Heather Watson
6. K. Ong

Citations in the corpus

• Bone tissue engineering: A review in bone biomimetics and drug delivery strategies (2009, background): “Medical expenses relating to fracture, reattachment, and replacement of hip and knee joint was estimated to be over $20 billion (USD) in 2003, and predicted to increase to over $74 (USD) billion by the year 2015.(1,2) Spinal arthrodesis is another example of a surgery typically requiring substantial”
• Economic burden of periprosthetic joint infection in the United States. (2012, methodology): “The true economic burden of PJI on the US health care is currently unknown as there are very few published studies relevant to this issue [3,4,12-14].”
• Prosthetic Joint Infection Risk after TKA in the Medicare Population (2010, methodology): “In the United States, where a joint arthroplasty registry has not yet been implemented, the Medicare claims data have been used effectively in longitudinal analysis of mortality, morbidity, and revision after joint arthroplasty [1, 11 , 12].”